TABLE 1.

Characteristics of patients

Group and patient no.	Diagnosis yr	T-cell count (cells/ml)		HIV-1 RNA (copies/ml)	HLA Class I			HIV-1 RNA (copies/ml) determined by single-copy assay	Time (yr) with viral load of <50 copies/ml
		CD4	CD8		A	B	C
LTNP
4	1985	1,063	1,088	<50	1, 31	8, 57	6, 7	8
7	1985	277	385	<50	1, 2	57	6	4
8	1985	664	1,120	<50-930	11, 23	44, 57	4, 6
33	1995	955	881	<50	2, 30	13, 57	6	<1
34	1989	1,746	1,164	<50	1, 2	8, 57	6, 7	48
37	1998	1,616	707	<50	30	42, 57	17, 18	16.3
38	1990	1,329	1,243	<50	2, 24	44, 57	5, 6	1
47	1994	500	1,284	<50	1, 74	57, 81	7, 18	4
58	1989	485	277	<50	30, 74	15, 57	3, 8	<1
59	1986	833	549	<50	23, 30	7, 57	7, 15
65	1993	865	388	<50	30, 74	14, 57	2, 8	4
66	1992	1,488	713	<50	2, 30	13, 57	6	<1
68	1986	1,362	1,055	<50	3, 29	57, 81	18	5
71	1996	1,300	816	<50	1, 24	38, 57	6, 12	<1
79	1998	520	780	<50	1, 30	42, 57	7, 17	<1
17	1985	1,073	1,051	<50	2, 26	27, 38	1, 12	1.5
32	1994	785	328	<50	1, 32	8, 27	1, 7	8.3
48	1989	834	417	<50	1, 33	8, 53	1, 4	19.3
49	1992	1,084	784	<50	3, 68	40, 53	2, 4	23
60	1985	992	1,110	<50	3, 11	35, 51	4, 15	9.6
61	2004	751	594	<50	2, 29	44, 49	7, 16	1.7
62	1985	1,452	807	<50	1, 32	35, 73	4, 15	<1
67	1982	1,308	880	<50	32	27, 44	1, 5	43.4
Rx <50a
27	1993	466	519	<50	2, 36	15, 42	3, 17	<1	8
101	1986	632	902	<50	1, 31	51, 57	6, 15	2.3	3
113	1991	510	1,021	<50	1, 2	45, 57	7, 16	1.4	2
126	1991	829	1,525	<50	1, 68	8, 57	7, 18	<1	4
129	1988	445	783	<50	2, 32	15, 27	1, 2	3	9
132	1995	1,409	479	<50	30, 66	40, 57	3, 7	<1	10
134	2003	737	590	<50	68	15, 27	3	<1	1.5
141	2001	408	553	<50	2, 24	35, 49	3, 7	13.8	5
142	1994	759	821	<50	2, 68	27, 40	1, 3		0.75
143	1985	498	581	<50	2, 11	15, 27	1, 4		3
144	1986	741	412	<50	3, 26	7, 57	6, 7		10
151	1994	515	1,245	<50	2, 23	45, 57	16, 18	<1	6
152	1988	476	1,664	<50	2	44, 57	5, 6	6	6
153	1993	968	1,338	<50	2	15, 57	3, 6	1	5
156	1987	204	1,151	<50	1, 24	35, 57	6, 12	<1	3
157	1987	626	1,065	<50	2, 24	52, 57	6, 12	<1	8
158	2001	959	750	<50	1, 32	8, 35	4, 7	13	5
159	1997	781	521	<50	11	15	8	<1	9
160	1996	922	820	<50	26, 68	15, 18	4, 5	<1	4
161	2001	521	695	<50	11, 68	27	2, 7	1	6
162	1997	659	678	<50	3	14, 35	4, 8	<1	5
163	1987	668	789	<50	24, 30	18, 49	7, 12	14	6
164	1987	1,004	938	<50	24, 31	7, 27	2, 7	5	3
165	2001	604	935	<50	11, 24	35	4	2	3
166	1994	247	447	<50	2, 11	8, 15	3, 8	4	2
167	1986	649	508	<50	2, 3	14, 15	3, 8	<1	5
168	1990	1,167	1,228	<50	3, 32	14	8	<1	4
169	1989	476	987	<50	2, 3	7, 14	7, 8	<1	6
170	1994	561	546	<50	23, 68	7, 53	4, 7	29	5
171	1995	589	828	<50	25, 26	8, 49	7	1	7
172	1988	729	1,200	<50	2	13, 35	3	<1	11
173	1988	599	889	<50	2	15, 58	3	<1	2
174	1992	675	459	<50	33, 74	42, 53	4, 17	<1	7
175	1994	532	627	<50	11, 24	35, 40	3, 4	<1	6
176	2000	382	665	<50	2, 23	45, 58	6	1	2
177	1985	555	750	<50	1, 2	7, 40	3, 7	4	4
178	2002	498	227	<50	2, 30	45, 50	4, 16	<1	5
179	1990	501	866	<50	2, 25	7, 44	5, 7	10	9
185	1991	512	668	<50	34, 36	7, 44	7	4	6
187	1998	307	247	<50	2, 30	18, 58	5, 6	<1	4
188	1990	642	708	<50	1, 24	7, 8	7	2.6	8
189	1986	800	990	<50				1	3
190	1995	729	496	<50	2, 68	35, 44	4, 5	<1	4
191	2004	562	1,002	<50	29	13, 51	1, 6	<1	2
192	1997	568	1,237	<50	2, 74	7, 58	3, 7	53	4
199	2002	687	563	<50	2, 24	14, 15	1, 8	1.2	2.5
250	1990	400	991	<50	2, 32	13, 14	6, 8	12.2	10
251	1987	351	532	<50				1	5.75
252	2002	434	337	<50				<1	3
253	2000	505	949	<50	2, 68	40, 58	3	<1	5
254	1984	481	1,213	<50	3, 25	14, 18	8, 12	<1	3
255	1998	507	583	<50	2, 3	13, 35	4, 6	<1	2
256	2003	587	871	<50	2, 29	49	7	<1	1.75
257	1991	915	1,548	<50	2	37, 39	6, 7	<1	10
258	1983	641	1,654	<50	1, 30	15, 44	3, 4	4	7.25

^aTreated progressors with a viral load of <50 copies/ml.